U.S. Communicable Disease Center’s VAERS data released today showed 118,902 reports of adverse events following COVID vaccines, including 3,544 deaths and 12,619 serious injuries between Dec. 14, 2020 and April 23, 2021.
In the U.S., 222.3 million COVID vaccine doses had been administered as of April 23. This includes 97 million doses of Moderna’s vaccine, 117 million doses of Pfizer and 8 million doses of the Johnson &Johnson (J&J) COVID vaccine.
Of the 3,544 deaths reported as of April 23, 25% occurred within 48 hours of vaccination, 17% occurred within 24 hours and 40% occurred in people who became ill within 48 hours of being vaccinated.
This week’s data included three reports of deaths among teens under age 18, including two 15-year-olds and one 16-year-old who died unexpectedly from a blood clot 11 days after receiving her first Pfizer dose.
A 15-year-old female died of cardiac arrest after receiving the second dose of the Moderna vaccine, and a 15-year-old male died of cardiac failure two days after receiving the Pfizer vaccine.
This week’s VAERS data show:
- 21% of deaths were related to cardiac disorders.
- 54% of those who died were male, 44% were female and the remaining death reports did not include gender of the deceased.
- The average age of death was 75.3 and the youngest deaths reported include two 15-year-olds (VAERS I.D. 1187918 and 1242573 ) and a 16-year-old (VAERS I.D. 1225942). There were other reported deaths in children under 16 that could not be confirmed or contained obvious errors.
- As of April 23, 598 pregnant women reported adverse events related to COVID vaccines, including 170 reports of miscarriage or premature birth.
- Of the 1,099 cases of Bell’s Palsy reported, 51% of cases were reported after Pfizer-BioNTech vaccinations, 39% following vaccination with the Moderna vaccine and 131 cases or 12% of Bell’s Palsy were reported in conjunction with J&J.
- There were 121 reports of Guillain-Barré Syndrome with 44% of cases attributed to Pfizer, 43% to Moderna and 17% to J&J.
- There were 33,673 reports of anaphylaxis with 39% of cases attributed to Pfizer’s vaccine, 44% to Moderna and 16% to J&J.